Related Experiment Video
Updated: Jul 9, 2026
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Mechanisms of the RGS12-GPX4-ACSL4 signaling axis in regulating ferroptosis during myocardial ischemia-reperfusion
Congna Zi1, Zhiwei Zhang2, Tao Zhang1
1Department of Anesthesiology, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075061, China.
Abstract:
Acute myocardial infarction (AMI) is one of the leading causes of death worldwide. Timely reperfusion therapy following AMI can effectively salvage ischemic cardiomyocytes. However, myocardial ischemia-reperfusion injury (MIRI), which inevitably occurs during the process of blood supply recovery, may affect the therapeutic outcome. During MIRI, various forms of cell death, such as apoptosis, autophagy and pyroptosis, are involved. Ferroptosis is a recently discovered form of programmed cell death. Studies have shown that ferroptosis is closely related to the progression of MIRI. In the regulation of ferroptosis, GPX4 inhibits ferroptosis by clearing lipid peroxides, whereas ACSL4 promotes lipid peroxidation and drives ferroptosis. In addition to known regulatory factors, recent studies have found that Regulator of RGS12, a key protein in the RGS family, plays an important role in ischemia-reperfusion injury. The deletion of Regulator of RGS12 significantly reduces the incidence of ferroptosis in cardiomyocytes, whereas its overexpression exacerbates ferroptosis. This phenomenon may be related to the regulation of iron metabolism-related signaling pathways by RGS12. This review aims to summarize the molecular mechanisms by which RGS12 influences the progression of ferroptosis through regulating GPX4 and ACSL4 expression, thereby contributing to MIRI.
Insights
Regulator of RGS12 influences ferroptosis in myocardial ischemia-reperfusion injury (MIRI). Its deletion reduces ferroptosis, while overexpression worsens it, impacting treatment outcomes.
Area of Science:
- Cardiology
- Cell Death Research
- Molecular Biology
Background:
- Acute myocardial infarction (AMI) is a major global health concern.
- Myocardial ischemia-reperfusion injury (MIRI) complicates reperfusion therapy for AMI.
- Ferroptosis, a form of programmed cell death, is increasingly implicated in MIRI progression.
Purpose of the Study:
- To review the molecular mechanisms by which Regulator of RGS12 affects ferroptosis in MIRI.
- To elucidate the role of RGS12 in regulating key ferroptosis mediators GPX4 and ACSL4.
- To understand how RGS12 influences iron metabolism signaling in the context of MIRI.
Main Methods:
- Literature review of studies on MIRI, ferroptosis, and Regulator of RGS12.
- Analysis of research investigating GPX4 and ACSL4 as ferroptosis regulators.
- Examination of studies linking RGS12 to iron metabolism and cell death pathways.
Main Results:
- Regulator of RGS12 plays a significant role in MIRI.
- Deletion of RGS12 decreases ferroptosis in cardiomyocytes; overexpression increases it.
- RGS12 influences ferroptosis by modulating the expression of GPX4 and ACSL4.
Conclusions:
- Regulator of RGS12 is a key factor in ferroptosis during MIRI.
- Targeting RGS12 may offer a novel therapeutic strategy for MIRI.
- Further research into RGS12's role in iron metabolism is warranted for MIRI treatment.
